Pluristem Story

<div class='circular--portrait' style='background:#4E8BFC;color: #ffffff;font-size:4em;'>PT</div>
Pluristem Stock News module provides quick insight into current market opportunities from investing in Pluristem Therapeutc. Use historical and current headlines to determine the investment entry and exit points. Many technical investors use Pluristem Therapeutc stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Check out Your Equity Center.

Search Today's Stock News ...

 
Refresh
Pluristem Therapeutc stock news, alerts, and headlines are usually related to their technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Pluristem daily returns and investor perception about the current pice of Pluristem Therapeutc as well as its diversification or hedging effects on your existing portfolios.
Acquisition by Levi Rami Avraham of 20000 shares of Pluristem Therapeutics subject to Rule 16b-3
Filed transaction by Pluristem Therapeutics In director. Grant, award or other acquisition pursuant to Rule 16b-3(d)

Pluristem insider trading alert for grant of restricted stock units by Levi Rami Avraham, the corporate stakeholder, on 7th of January 2021. This event was filed by Pluristem Therapeutics In with SEC on 2021-01-07. Statement of changes in beneficial ownership - SEC Form 4
Follow Benchmarks with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker

Pluristem Therapeutc Fundamental Analysis

We analyze Pluristem Therapeutc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Pluristem Therapeutc using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Pluristem Therapeutc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Earnings Per Share

Earnings Per Share Comparative Analysis

Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.

Peers

Your Trending Equities

S  2.13   
0%
100.0%
T  0.67   
0%
31.0%
TGT  0.45   
0%
20.0%
WFC  0.43   
0%
20.0%
C  0.43   
0%
20.0%
MET  0.33   
0%
15.0%
AAPL  0.14   
0%
6.0%
CVS  0.12   
0%
5.0%
HD  0.27   
12.0%
0%
UPS  0.28   
13.0%
0%
CVX  0.32   
15.0%
0%
IBM  0.46   
21.0%
0%
AA  0.90   
42.0%
0%
BBY  1.53   
71.0%
0%
INTC  1.93   
90.0%
0%
AAL  2.09   
97.0%
0%
Check out Your Equity Center. Note that the Pluristem Therapeutc information on this page should be used as a complementary analysis to other Pluristem Therapeutc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Complementary Tools for Pluristem Therapeutc Stock analysis

When running Pluristem Therapeutc stock analysis, check to measure Pluristem Therapeutc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pluristem Therapeutc is operating at the current time. Most of Pluristem Therapeutc's stock examination focuses on studying past and present price action to predict the probability of Pluristem Therapeutc's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Pluristem Therapeutc's price. Additionally, you may evaluate how the addition of Pluristem Therapeutc to your portfolios can decrease your overall portfolio volatility.
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go